
Vesalius Biocapital is a Private Equity fund based in Luxemburg, offering venture capital to young European innovative life science companies. Being a mid-size venture capital fund, our aim is to invest in young, early and mid-stage European life science companies focused on creative innovative drugs, diagnostics and cutting-edge biomedical technologies. We are building a diversified portfolio of companies with a balanced risk structure and with financial attractiveness translating into above average returns on investment